Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

Leishmaniasis

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...

American Trypanosomiasis

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The health and economic repercussions of declining MMR coverage in the United States.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Estimating US savings on outpatient prescription pharmaceuticals from international reference pricing.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

The synergy of therapeutic vaccination and timely diagnosis for TB control in high-burden settings: Nunavut as a case study.

Journal of clinical tuberculosis and other mycobacterial diseases·2025

Same author

Racial and Ethnic Disparities in Meningococcal Vaccination Coverage and Disease Burden Among U.S. Adolescents.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2025

Same author

Quantifying the mortality and morbidity impact of medicaid work requirements: a modeling study.

Lancet regional health. Americas·2025

Same author

School-Level Gaps in MMR Coverage as the Fuel for Measles Outbreaks.

Annals of internal medicine·2025

Search research articles

Related Experiment Video

Updated: Jul 18, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Modeling targeted ivermectin treatment for controlling river blindness.

Eric M Poolman¹, Alison P Galvani

¹Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520-8034, USA. eric.poolman@yale.edu

The American Journal of Tropical Medicine and Hygiene

|November 25, 2006

Summary

Targeting ivermectin treatment for onchocerciasis in heterogeneous populations reduces drug doses by 20-25%. This strategy lowers adverse effects and may delay ivermectin resistance, improving public health outcomes.

More Related Videos

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

A Model for Experimental Exposure of Humans to Larval Ixodes scapularis Ticks

A Model for Experimental Exposure of Humans to Larval Ixodes scapularis Ticks

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Jul 18, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

A Model for Experimental Exposure of Humans to Larval Ixodes scapularis Ticks

A Model for Experimental Exposure of Humans to Larval Ixodes scapularis Ticks

Published on: December 1, 2023

Area of Science:

Epidemiology
Parasitology
Public Health

Background:

Onchocerciasis transmission is influenced by significant host heterogeneity in exposure.
Understanding this heterogeneity is crucial for effective intervention strategies.

Purpose of the Study:

To develop and utilize a mathematical model incorporating host heterogeneity to evaluate targeted ivermectin interventions for onchocerciasis.
To compare the efficacy and resource requirements of targeted versus untargeted ivermectin allocation.

Main Methods:

Mathematical modeling of onchocerciasis transmission dynamics.
Incorporation of host exposure heterogeneity into the model.
Simulation of targeted ivermectin treatment strategies.

Main Results:

Targeted ivermectin allocation in heterogeneous populations requires 20-25% fewer doses compared to untargeted strategies.
This approach significantly reduces the overall public health burden of onchocerciasis.
Targeted allocation minimizes the risk of adverse effects associated with ivermectin treatment.

Conclusions:

Mathematical modeling supports targeted ivermectin allocation as a more efficient strategy for onchocerciasis control.
This approach offers substantial benefits in terms of reduced drug usage, lower adverse event risk, and potential mitigation of drug resistance.
Optimizing treatment allocation based on host heterogeneity is key to advancing public health interventions for parasitic diseases.